Evidence map›Paper›PMID 41686098›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2026

Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].

Michele Carbone, Christopher Amos, Richard L Attanoos, Mattia Boeri, Raphael Bueno, Paul A Bunn, Lucian R Chirieac, Benjamin Cooper, Dean Fennell, Francoise Galateau-Salle and 28 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors.

Michele CarboneThoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, Hawaii; Università Magna Græcia, Scuola di Medicina, Anatomia Patologica, Catanzaro, Italy. Electronic address: mcarbone@cc.hawaii.edu.
Christopher AmosUniversity of New Mexico, New Mexico, Albuquerque.
Richard L AttanoosDepartment of Cellular Pathology, University Hospital of Wales and School of Medicine, Cardiff University, Wales, United Kingdom.
Mattia BoeriUnit of Epigenomics & Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Raphael BuenoDivision of Thoracic Surgery, Lung Center and International Mesothelioma Program, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Paul A BunnDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Lucian R ChirieacDepartment of Pathology, Mount Sinai Hospital, New York, New York.
Benjamin CooperDepartment of Radiation Oncology, NYU Langone Health, New York, New York.
Dean FennellUniversity of Leicester & University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
Francoise Galateau-SalleCollege MESOPATH, Paris, France.
Lydia GiannakouThoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Chandra V GoparajuDepartment of Cardiothoracic Surgery, NYU Langone Health, New York, New York.
Raffit HassanThoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Paul HofmanLaboratoire de Pathologie Clinique et expérimentale CHU, Nice, IHU RespirERA Université côte d'Azur Nice, Nice, France.
Mark G KrisThoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, New York.
Weimin MaoDepartment of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, People's Republic of China.
Michael MinaaiThoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Tsetsuya MitsudomiDivision of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
Thierry J MolinaDepartment of Pathology, Hôpitaux Universitaires Robert Debré et Necker Enfants-Malades, AP-HP, Université Paris Cité, Paris, France.
Luis M MontuengaSolid Tumors Program, Clínica Universidad de Navarra Cancer Center and CIMA, University of Navarra, Pamplona, Spain; IdisNa, Pamplona, Spain; CIBERONC, Madrid, Spain.
Kazuki NabeshimaDepartment of Diagnostic Pathology, Pathological Diagnosis Center, Fukuoka Tokushukai Hospital Fukuoka University, Fukuoka Prefecture, Japan.
Antonio PassaroEuropean Institute of Oncology IRCCS, Milan, Italy.
Solange PetersDepartment of Oncology, University Hospital CHUV, Lausanne, Switzerland.
Arun RajanThoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
David B RichardsonUC Irvine Joe C. Wen School of Population & Public Health, Irvine, California.
Hilary RobbinsGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Christian RolfoDepartment of Internal Medicine, Division of Medical Oncology, The Arthur G. James Comprehensive Cancer Center, Columbus, Ohio.
Charles M RudinDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Jonathan M SametColorado School of Public Health, Aurora, Colorado.
Arnaud ScherpereelService de Pneumologie et d'Oncologie Thoracique CHU de Lille - Hôpital Albert Calmette, Lille, France.
David S SchrumpThoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Gabriella SozziUnit of Epigenomics & Biomarkers of Solid Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Emanuela TaioliInstitute for Translational Epidemiology and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Silvia D VisonàDepartment of Public Health, Experimental and Forensic Medicine, Unit of Legal Medicine and Forensic Sciences, University of Pavia, Pavia, Italy.
Haining YangThoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
Yoshie YoshikawaThoracic Oncology Program, University of Hawaii Cancer Center, Honolulu, Hawaii.
An ZhaoZhejiang Cancer Institute, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, People's Republic of China.
Harvey I PassDepartment of Cardiothoracic Surgery, NYU Langone Health, New York, New York.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41686098
PMCPMC13289125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.